XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Total Shareholders' Equity Attributable to Acushnet Holdings Corp.
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss, Net of Tax
Retained Earnings
Treasury Stock
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2023     63,429          
Beginning balance at Dec. 31, 2023 $ 903,087 $ 864,235 $ 63 $ 808,615 $ (104,349) $ 159,906 $ 0 $ 38,852
Changes in stockholders' equity                
Net income (loss) 211,265 215,414       215,414   (4,149)
Other comprehensive income (loss) (3,750) (3,750)     (3,750)      
Share-based compensation 23,522 23,522   23,522        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     442          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (16,600) (16,600)   (16,600)        
Purchases of common stock (Note 10) (in shares)     (2,215)          
Purchases of common stock (Note 10) (143,584) (143,584) $ (1) (28,289)   (115,294)    
Share repurchase liability (Note 10) (32,523) (32,523)         (32,523)  
Dividends and dividend equivalents declared (41,815) (41,815)       (41,815)    
Redemption value adjustment (Note 1) (1,000) (1,000)       (1,000)    
Ending balance (in shares) at Sep. 30, 2024     61,656          
Ending balance at Sep. 30, 2024 898,602 863,899 $ 62 787,248 (108,099) 217,211 (32,523) 34,703
Beginning balance (in shares) at Dec. 31, 2023     63,429          
Beginning balance at Dec. 31, 2023 903,087 864,235 $ 63 808,615 (104,349) 159,906 0 38,852
Changes in stockholders' equity                
Dividends and dividend equivalents declared (55,291)              
Ending balance (in shares) at Dec. 31, 2024     61,215          
Ending balance at Dec. 31, 2024 793,136 765,247 $ 61 787,725 (140,315) 180,276 (62,500) 27,889
Beginning balance (in shares) at Jun. 30, 2024     62,729          
Beginning balance at Jun. 30, 2024 898,709 863,693 $ 63 792,559 (123,038) 231,608 (37,499) 35,016
Changes in stockholders' equity                
Net income (loss) 55,911 56,224       56,224   (313)
Other comprehensive income (loss) 14,939 14,939     14,939      
Share-based compensation 8,883 8,883   8,883        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     7          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (246) (246)   (246)        
Purchases of common stock (Note 10) (in shares)     (1,080)          
Purchases of common stock (Note 10) (70,783) (70,783) $ (1) (13,948)   (56,834)    
Share repurchase liability (Note 10) 4,976 4,976         4,976  
Dividends and dividend equivalents declared (13,787) (13,787)       (13,787)    
Ending balance (in shares) at Sep. 30, 2024     61,656          
Ending balance at Sep. 30, 2024 898,602 863,899 $ 62 787,248 (108,099) 217,211 (32,523) 34,703
Changes in stockholders' equity                
Dividends and dividend equivalents declared (13,476)              
Ending balance (in shares) at Dec. 31, 2024     61,215          
Ending balance at Dec. 31, 2024 793,136 765,247 $ 61 787,725 (140,315) 180,276 (62,500) 27,889
Changes in stockholders' equity                
Net income (loss) 223,258 223,446       223,446   (188)
Other comprehensive income (loss) 20,686 20,686     20,686      
Share-based compensation 24,040 24,040   24,040        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     289          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (11,416) (11,416) $ 1 (11,417)        
Purchases of common stock (Note 10) (in shares)     (2,843)          
Purchases of common stock (Note 10) (187,966) (187,966) $ (3) (36,992)   (150,971)    
Share repurchase liability (Note 10) 62,500 62,500         62,500  
Dividends and dividend equivalents declared (43,262) (43,262)       (43,262)    
Redemption value adjustment (Note 1) (1,000) (1,000)       (1,000)    
Deconsolidation of VIE (Note 1) (27,701)             (27,701)
Ending balance (in shares) at Sep. 30, 2025     58,661          
Ending balance at Sep. 30, 2025 852,275 852,275 $ 59 763,356 (119,629) 208,489 0 0
Beginning balance (in shares) at Jun. 30, 2025     59,593          
Beginning balance at Jun. 30, 2025 808,519 808,519 $ 60 767,944 (121,205) 224,228 (62,508)  
Changes in stockholders' equity                
Net income (loss) 48,511 48,511       48,511    
Other comprehensive income (loss) 1,576 1,576     1,576      
Share-based compensation 8,510 8,510   8,510        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     21          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (452) (452)   (452)        
Purchases of common stock (Note 10) (in shares)     (953)          
Purchases of common stock (Note 10) (62,509) (62,509) $ (1) (12,646)   (49,862)    
Share repurchase liability (Note 10) 62,508 62,508         62,508  
Dividends and dividend equivalents declared (14,388) (14,388)       (14,388)    
Ending balance (in shares) at Sep. 30, 2025     58,661          
Ending balance at Sep. 30, 2025 $ 852,275 $ 852,275 $ 59 $ 763,356 $ (119,629) $ 208,489 $ 0 $ 0